Publicacións en colaboración con investigadores/as de University of Oxford (20)

2023

  1. Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists

    Communications biology, Vol. 6, Núm. 1, pp. 376

2017

  1. Gefitinib and EGFR gene copy number aberrations in esophageal cancer

    Journal of Clinical Oncology, Vol. 35, Núm. 20, pp. 2279-2287

2016

  1. IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 95, Núm. 5, pp. 1367-1377

2014

  1. Gefitinib for oesophageal cancer progressing after chemotherapy (COG): A phase 3, multicentre, double-blind, placebo-controlled randomised trial

    The Lancet Oncology, Vol. 15, Núm. 8, pp. 894-904

2009

  1. Proteomic analysis of HepaRG cells: A novel cell line that supports hepatitis B virus infection

    Journal of Proteome Research, Vol. 8, Núm. 1, pp. 118-122

  2. Proteomic analysis of integrin αIIbβ3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions

    Journal of Thrombosis and Haemostasis, Vol. 7, Núm. 10, pp. 1718-1726

2008

  1. A microtubule interactome: Complexes with roles in cell cycle and mitosis

    PLoS Biology, Vol. 6, Núm. 4, pp. 785-795

2007

  1. A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein

    Molecular and Cellular Proteomics, Vol. 6, Núm. 3, pp. 548-564

  2. Biomarker discovery from uveal melanoma secretomes: Identification of gp100 and cathepsin D in patient serum

    Journal of Proteome Research, Vol. 6, Núm. 7, pp. 2802-2811

2006

  1. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: Involvement of G6f, a novel platelet Grb2-binding membrane adapter

    Proteomics, Vol. 6, Núm. 19, pp. 5332-5343

  2. Isolation and characterization of cotiaractivase, a novel low molecular weight prothrombin activator from the venom of Bothrops cotiara

    Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1764, Núm. 5, pp. 863-871

  3. Proteome analysis of signaling cascades in human platelets

    Blood Cells, Molecules, and Diseases, Vol. 36, Núm. 2, pp. 152-156

  4. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker

    International Journal of Cancer, Vol. 119, Núm. 5, pp. 1014-1022

2005

  1. Applying proteomics technology to platelet research

    Mass Spectrometry Reviews, Vol. 24, Núm. 6, pp. 918-930

  2. Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling

    Immunity, Vol. 23, Núm. 6, pp. 621-634

  3. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS

    Proteomics, Vol. 5, Núm. 18, pp. 4980-4993

2004

  1. Abnormal cell cycle regulation in primary human uveal melanoma cultures

    Journal of Cellular Biochemistry, Vol. 93, Núm. 4, pp. 708-720

  2. Analyzing the platelet proteome

    Seminars in Thrombosis and Hemostasis, Vol. 30, Núm. 4, pp. 485-489

  3. Differential proteome analysis of TRAP-activated platelets: Involvement of DOK-2 and phosphorylation of RGS proteins

    Blood, Vol. 103, Núm. 6, pp. 2088-2095

  4. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry

    Proteomics, Vol. 4, Núm. 3, pp. 656-668